Compound Global Advisors’s HCA Healthcare HCA Stock Holding History

Compound Global Advisors’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-103	Closed	-$43.9K	–	19
2025 Q3	$43.9K	Buy	+103	New	+$39.9K	2.38%	16
2025 Q2	–	Sell	-753	Closed	-$225K	–	28
2025 Q1	$225K	Sell	753 -2,950	-80%	-$949K	1.33%	33
2024 Q4	$1.11M	Buy	+3,703	New	+$1.29M	4.52%	8

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Compound Global Advisors's HCA Position: Q4 2025 in Review

Compound Global Advisors sold out of HCA Healthcare (HCA) in Q4 2025, closing a stake of 103 shares — an estimated $43.9K sold.

Compound Global Advisors first reported a position in HCA in Q4 2024 and held it in 3 quarters. The position peaked at $1.11M in Q4 2024. 1,395 funds tracked by Wall St. Rank hold HCA as of Q4 2025.

Compound Global Advisors reported no remaining HCA Healthcare position as of Q4 2025 after selling out during the quarter.
Compound Global Advisors sold 103 HCA Healthcare shares in Q4 2025, an estimated $43.9K.
Compound Global Advisors first reported a position in HCA Healthcare in Q4 2024 and held it in 3 quarters.
Compound Global Advisors's HCA Healthcare position peaked at $1.11M in Q4 2024.
1,395 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2025.

Based on Compound Global Advisors's 13F filing for Q4 2025, filed 4 Feb 2026.